[The PI3KC2β kinase as a therapeutic target for myotubular myopathy]
- PMID: 38411417
- DOI: 10.1051/medsci/2023208
[The PI3KC2β kinase as a therapeutic target for myotubular myopathy]
References
-
- Hammond GRV, Burke JE. Novel roles of phosphoinositides in signaling, lipid transport, and disease. Curr Opin Cell Biol 2020; 63 : 57–67.
-
- Burke JE, Triscott J, Emerling BM, Hammond GRV. Beyond PI3Ks : targeting phosphoinositide kinases in disease. Nat Rev Drug Discov 2023; 22 : 357–86.
-
- Laporte J, Hu LJ, Kretz C, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 1996 ; 13 : 175–182.
-
- Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis 2008 ; 3 : 26.
-
- Dowling JJ, Vreede AP, Low SE, et al. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet 2009 ; 5 : e1000372.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources